cd14 selection macs purification Search Results


98
Miltenyi Biotec macs technology
Macs Technology, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd14+++selection+macs+purification/CD14+MicroBeads%2C+human/pmc09791252-227-10-12
Average 98 stars, based on 1 article reviews
macs technology - by Bioz Stars, 2026-10
98/100 stars
  Buy from Supplier

99
Miltenyi Biotec macs magnetic cell separation system
Macs Magnetic Cell Separation System, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd14+++selection+macs+purification/LS+Columns/pmc05471192-87-7-20
Average 99 stars, based on 1 article reviews
macs magnetic cell separation system - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc macs cd14 positive selection kit
Macs Cd14 Positive Selection Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd14+++selection+macs+purification/easysep+human+t+cell+isolation+kit/pm19696431-32-6-11
Average 90 stars, based on 1 article reviews
macs cd14 positive selection kit - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

97
Miltenyi Biotec direct cd14 isolation kit
Direct Cd14 Isolation Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd14+++selection+macs+purification/MS+Columns/pm42203024-80-16-23
Average 97 stars, based on 1 article reviews
direct cd14 isolation kit - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier

98
Miltenyi Biotec macs cd14 microbeads
Macs Cd14 Microbeads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd14+++selection+macs+purification/CD14+MicroBeads%2C+human+-+lyophilized/pm35964875-69-6-17
Average 98 stars, based on 1 article reviews
macs cd14 microbeads - by Bioz Stars, 2026-10
98/100 stars
  Buy from Supplier

96
Miltenyi Biotec cd14 antibody
FIG. 1. Cell surface expression of scavenger receptor CD36. Flow cytometric analysis of expression of CD36 in <t>CD14</t> circulating mono- cytes from nondiabetic control subjects (NDC), well-controlled dia- betic patients (WCD), and poorly controlled diabetic patients (PCD). After isolation by positive selection on the AutoMACS cell sorting system, CD14 monocytes were labeled with an anti–CD36-phyco- erythrin antibody. ‚, patients with type 2 diabetes; Œ, patients with type 1 diabetes; ‰, control subjects. Data are expressed as percentage of positive cells for CD36; n 13 (NDC), n 22 (WCD), n 27, (PCD); ***P < 0.0005.
Cd14 Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd14+++selection+macs+purification/CD14+Antibody%2C+anti-human/pm16123369-69-37-42
Average 96 stars, based on 1 article reviews
cd14 antibody - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

95
Miltenyi Biotec macs separation cd14 microbeads
FIG. 1. Cell surface expression of scavenger receptor CD36. Flow cytometric analysis of expression of CD36 in <t>CD14</t> circulating mono- cytes from nondiabetic control subjects (NDC), well-controlled dia- betic patients (WCD), and poorly controlled diabetic patients (PCD). After isolation by positive selection on the AutoMACS cell sorting system, CD14 monocytes were labeled with an anti–CD36-phyco- erythrin antibody. ‚, patients with type 2 diabetes; Œ, patients with type 1 diabetes; ‰, control subjects. Data are expressed as percentage of positive cells for CD36; n 13 (NDC), n 22 (WCD), n 27, (PCD); ***P < 0.0005.
Macs Separation Cd14 Microbeads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd14+++selection+macs+purification/CD14+MicroBeads%2C+non-human+primate/pmc04127066-70-12-16
Average 95 stars, based on 1 article reviews
macs separation cd14 microbeads - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc cd14 positive selection kit macs cd14 micro beads
FIG. 1. Cell surface expression of scavenger receptor CD36. Flow cytometric analysis of expression of CD36 in <t>CD14</t> circulating mono- cytes from nondiabetic control subjects (NDC), well-controlled dia- betic patients (WCD), and poorly controlled diabetic patients (PCD). After isolation by positive selection on the AutoMACS cell sorting system, CD14 monocytes were labeled with an anti–CD36-phyco- erythrin antibody. ‚, patients with type 2 diabetes; Œ, patients with type 1 diabetes; ‰, control subjects. Data are expressed as percentage of positive cells for CD36; n 13 (NDC), n 22 (WCD), n 27, (PCD); ***P < 0.0005.
Cd14 Positive Selection Kit Macs Cd14 Micro Beads, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd14+++selection+macs+purification/rosettesep+ab+mixture/us09422350-276-9-18
Average 90 stars, based on 1 article reviews
cd14 positive selection kit macs cd14 micro beads - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


FIG. 1. Cell surface expression of scavenger receptor CD36. Flow cytometric analysis of expression of CD36 in CD14 circulating mono- cytes from nondiabetic control subjects (NDC), well-controlled dia- betic patients (WCD), and poorly controlled diabetic patients (PCD). After isolation by positive selection on the AutoMACS cell sorting system, CD14 monocytes were labeled with an anti–CD36-phyco- erythrin antibody. ‚, patients with type 2 diabetes; Œ, patients with type 1 diabetes; ‰, control subjects. Data are expressed as percentage of positive cells for CD36; n 13 (NDC), n 22 (WCD), n 27, (PCD); ***P < 0.0005.

Journal: Diabetes

Article Title: Activation of peripheral blood CD14+ monocytes occurs in diabetes.

doi: 10.2337/diabetes.54.9.2779

Figure Lengend Snippet: FIG. 1. Cell surface expression of scavenger receptor CD36. Flow cytometric analysis of expression of CD36 in CD14 circulating mono- cytes from nondiabetic control subjects (NDC), well-controlled dia- betic patients (WCD), and poorly controlled diabetic patients (PCD). After isolation by positive selection on the AutoMACS cell sorting system, CD14 monocytes were labeled with an anti–CD36-phyco- erythrin antibody. ‚, patients with type 2 diabetes; Œ, patients with type 1 diabetes; ‰, control subjects. Data are expressed as percentage of positive cells for CD36; n 13 (NDC), n 22 (WCD), n 27, (PCD); ***P < 0.0005.

Article Snippet: Human venous blood was collected in a lithium heparin tube and processed within 1–2 h. CD14 monocytes were isolated directly from total blood with a magnetic activated cell sorting system (AutoMACS; Miltenyi Biotech) using microbeads coated with CD14 antibody (MACS CD14 MicroBeads; Miltenyi Biotech).

Techniques: Expressing, Control, Isolation, Selection, FACS, Labeling

FIG. 2. CD36 and CD68 mRNA expression. Expression of CD36 mRNA (A) and expression of CD68 mRNA (B) in CD14 monocytes from control subjects (NDC), well-controlled diabetic patients (WCD), and poorly controlled diabetic patients (PCD). ‚, patients with type 2 diabetes; Œ, patients with type 1 diabetes; and ‰, control subjects. The mRNA level was quantified using real-time RT-PCR; n 12 (NDC), n 16 (WCD), n 16 (PCD). *P < 0.05; ***P < 0.005; ***P < 0.0005.

Journal: Diabetes

Article Title: Activation of peripheral blood CD14+ monocytes occurs in diabetes.

doi: 10.2337/diabetes.54.9.2779

Figure Lengend Snippet: FIG. 2. CD36 and CD68 mRNA expression. Expression of CD36 mRNA (A) and expression of CD68 mRNA (B) in CD14 monocytes from control subjects (NDC), well-controlled diabetic patients (WCD), and poorly controlled diabetic patients (PCD). ‚, patients with type 2 diabetes; Œ, patients with type 1 diabetes; and ‰, control subjects. The mRNA level was quantified using real-time RT-PCR; n 12 (NDC), n 16 (WCD), n 16 (PCD). *P < 0.05; ***P < 0.005; ***P < 0.0005.

Article Snippet: Human venous blood was collected in a lithium heparin tube and processed within 1–2 h. CD14 monocytes were isolated directly from total blood with a magnetic activated cell sorting system (AutoMACS; Miltenyi Biotech) using microbeads coated with CD14 antibody (MACS CD14 MicroBeads; Miltenyi Biotech).

Techniques: Expressing, Control, Quantitative RT-PCR

FIG. 3. DiI-OxLDL uptake by CD14 circulating monocytes. CD14 monocytes from control subjects (NDC), well-controlled diabetic pa- tients (WCD), and poorly controlled diabetic patients (PCD) were incubated in presence of DiI-OxLDL (50 g/ml) alone (A) or with an anti-CD36 monoclonal antibody (20 g/ml) (B) for 4 h at 4°C or 37°C. After washes and lysis of the cells, DiI-OxLDL uptake was assessed by spectrofluorimetry (excitation, 520 nm; emission, 580 nm). Data are expressed as means SE. For the DiI-OxLDL uptake experiments, n 7 (NDC), n 7 (WCD), n 9 (PCD); *P < 0.05, **P < 0.005. For the DiI-OxLDL uptake in presence of anti-CD36 monoclonal antibody, three samples per group were analyzed.

Journal: Diabetes

Article Title: Activation of peripheral blood CD14+ monocytes occurs in diabetes.

doi: 10.2337/diabetes.54.9.2779

Figure Lengend Snippet: FIG. 3. DiI-OxLDL uptake by CD14 circulating monocytes. CD14 monocytes from control subjects (NDC), well-controlled diabetic pa- tients (WCD), and poorly controlled diabetic patients (PCD) were incubated in presence of DiI-OxLDL (50 g/ml) alone (A) or with an anti-CD36 monoclonal antibody (20 g/ml) (B) for 4 h at 4°C or 37°C. After washes and lysis of the cells, DiI-OxLDL uptake was assessed by spectrofluorimetry (excitation, 520 nm; emission, 580 nm). Data are expressed as means SE. For the DiI-OxLDL uptake experiments, n 7 (NDC), n 7 (WCD), n 9 (PCD); *P < 0.05, **P < 0.005. For the DiI-OxLDL uptake in presence of anti-CD36 monoclonal antibody, three samples per group were analyzed.

Article Snippet: Human venous blood was collected in a lithium heparin tube and processed within 1–2 h. CD14 monocytes were isolated directly from total blood with a magnetic activated cell sorting system (AutoMACS; Miltenyi Biotech) using microbeads coated with CD14 antibody (MACS CD14 MicroBeads; Miltenyi Biotech).

Techniques: Control, Incubation, Lysis

FIG. 4. Expression of MCP-1 (A), ICAM-1 (B), and VCAM-1 (C) mRNA in CD14 monocytes from control subjects (NDC), well-controlled diabetic patients (WCD), and poorly controlled diabetic patients (PCD). Expression of gene mRNA level was determined by real-time RT-PCR; n 12 (NDC), n 16 (WCD), n 16 (PCD). Data are expressed as means SD,*P < 0.05. FIG. 5. Expression of PPAR (A), PPAR (B), and PPAR (C) mRNA in CD14 monocytes from control subjects (NDC), well-controlled diabetic patients (WCD), and poorly controlled diabetic patients (PCD). The mRNA level was quantified using real-time RT-PCR; 12 (NDC), n 16 (WCD), n 16 (PCD). Data are expressed as means SD,*P < 0.05.

Journal: Diabetes

Article Title: Activation of peripheral blood CD14+ monocytes occurs in diabetes.

doi: 10.2337/diabetes.54.9.2779

Figure Lengend Snippet: FIG. 4. Expression of MCP-1 (A), ICAM-1 (B), and VCAM-1 (C) mRNA in CD14 monocytes from control subjects (NDC), well-controlled diabetic patients (WCD), and poorly controlled diabetic patients (PCD). Expression of gene mRNA level was determined by real-time RT-PCR; n 12 (NDC), n 16 (WCD), n 16 (PCD). Data are expressed as means SD,*P < 0.05. FIG. 5. Expression of PPAR (A), PPAR (B), and PPAR (C) mRNA in CD14 monocytes from control subjects (NDC), well-controlled diabetic patients (WCD), and poorly controlled diabetic patients (PCD). The mRNA level was quantified using real-time RT-PCR; 12 (NDC), n 16 (WCD), n 16 (PCD). Data are expressed as means SD,*P < 0.05.

Article Snippet: Human venous blood was collected in a lithium heparin tube and processed within 1–2 h. CD14 monocytes were isolated directly from total blood with a magnetic activated cell sorting system (AutoMACS; Miltenyi Biotech) using microbeads coated with CD14 antibody (MACS CD14 MicroBeads; Miltenyi Biotech).

Techniques: Expressing, Control, Quantitative RT-PCR

FIG. 6. Circulating monocyte adhesion to HAoEC. After being labeled with CMFDA, CD14 monocytes from control subjects (NDC), well- controlled diabetic patients (WCD), and poorly controlled diabetic patients (PCD) were incubated in presence of HAoEC at 37°C for 45 min. After PBS washes, the numbers of attached monocytes per square millimeter were quantified on five randomly chosen fields, using an inverted microscope. Data are expressed as means SE. For monocyte adhesion experiments, n 10 (NDC), n 8 (WCD), n 6 (PCD), ***P < 0.0005.

Journal: Diabetes

Article Title: Activation of peripheral blood CD14+ monocytes occurs in diabetes.

doi: 10.2337/diabetes.54.9.2779

Figure Lengend Snippet: FIG. 6. Circulating monocyte adhesion to HAoEC. After being labeled with CMFDA, CD14 monocytes from control subjects (NDC), well- controlled diabetic patients (WCD), and poorly controlled diabetic patients (PCD) were incubated in presence of HAoEC at 37°C for 45 min. After PBS washes, the numbers of attached monocytes per square millimeter were quantified on five randomly chosen fields, using an inverted microscope. Data are expressed as means SE. For monocyte adhesion experiments, n 10 (NDC), n 8 (WCD), n 6 (PCD), ***P < 0.0005.

Article Snippet: Human venous blood was collected in a lithium heparin tube and processed within 1–2 h. CD14 monocytes were isolated directly from total blood with a magnetic activated cell sorting system (AutoMACS; Miltenyi Biotech) using microbeads coated with CD14 antibody (MACS CD14 MicroBeads; Miltenyi Biotech).

Techniques: Labeling, Control, Incubation, Inverted Microscopy